ESGE guidelines: update on endoscopic ultrasound-guided sampling

Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway 

  • The European Society of Gastrointestinal Endoscopy (ESGE) offers an updated guideline for endoscopic ultrasound (EUS)-guided sampling in gastroenterology, representing evidence-based consensus on best practices as of early 2017.
  • The committee cautions that all decisions require consideration of clinical context and resource availability.

Highlights

  • EUS-guided sample recommended for pancreatic solid lesions as first-line procedure (strong recommendation).
  • With inconclusive/negative results but high degree of suspicion, recommendation is reevaluation of pathology slides, repeat sampling, or surgery (weak recommendation).
  • With pancreatitis and pancreatic mass, negative sampling results require cautious interpretation (strong recommendation).
  • For esophageal cancer, use EUS-guided sample for lymph node assessment (T1, maybe T2 adenocarcinoma), possible metastatic lesions (eg, liver) (weak recommendation).
  • EUS-guided sampling recommended for solid liver masses. 
  • EUS-guided sampling recommended for lymphadenopathy of unknown origin if outcomes would guide patient management and no superficial sites accessible.

Study design

 

  • Separate task forces addressed key questions under different subject headings.